Emageon, HSS draw out merger closing to February
Health Systems Solutions (HSS) and Emageon have agreed to extend the closing date for their pending merger to Feb. 11.
“We are pleased that, with the cooperation of Emageon, we were able to come up with a timetable for the completion of the merger and we are confident that the combined enterprise will offer great opportunities for our shareholders, employees and customers," said Stan Vashovsky, CEO and board chairman of the New York City-based HSS. “This extension will also allow us additional time to complete our integration plan for our technologies. As a result, we will be in a better position to immediately serve the market upon closing.”
"Emageon is pleased that HSS and Stanford International Bank Limited have shown a commitment to complete our transaction and we look forward to completing the merger promptly for the benefit of our investors and maximizing the HSS/Emageon business opportunities for our customers and employees," said Chuck Jett, CEO of the Birmingham, Ala.-based Emageon.
Each of the companies said they will file a current report on Form 8-K with the Securities and Exchange Commission, describing the amendments that were made to the transaction documents.
“We are pleased that, with the cooperation of Emageon, we were able to come up with a timetable for the completion of the merger and we are confident that the combined enterprise will offer great opportunities for our shareholders, employees and customers," said Stan Vashovsky, CEO and board chairman of the New York City-based HSS. “This extension will also allow us additional time to complete our integration plan for our technologies. As a result, we will be in a better position to immediately serve the market upon closing.”
"Emageon is pleased that HSS and Stanford International Bank Limited have shown a commitment to complete our transaction and we look forward to completing the merger promptly for the benefit of our investors and maximizing the HSS/Emageon business opportunities for our customers and employees," said Chuck Jett, CEO of the Birmingham, Ala.-based Emageon.
Each of the companies said they will file a current report on Form 8-K with the Securities and Exchange Commission, describing the amendments that were made to the transaction documents.